Non-small cell lung cancer
Conditions
Interventions
Patients undergoing thoracoscopic lung cancer surgery who previously received TPVB with levobupivacaine alone:None
Patients undergoing thoracoscopic lung cancer surgery who previously received TPVB with levobupivacaine plus esketamine:None
Sponsors
Yixing Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Underwent elective thoracoscopic radical resection of non-small cell lung cancer at Yixing Hospital of Traditional Chinese Medicine; 2. Aged 18-75 years; 3. ASA physical status I-III; 4. Received general anesthesia combined with ultrasound-guided thoracic paravertebral block; 5. Complete medical records, anesthesia records, postoperative analgesia records, and primary outcome data.
Exclusion criteria
Exclusion criteria: 1. Contraindication to regional anesthesia; 2. History of chronic opioid use or chronic pain syndrome; 3. Severe hepatic impairment or severe renal impairment (eGFR <30 mL/min/1.73 m²); 4. Psychiatric disorder affecting pain or neuropsychiatric assessment; 5. Conversion to open thoracotomy or reoperation within 48 hours after surgery; 6. Missing key study data or incomplete records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative sufentanil consumption within 48 hours after surgery;Postoperative pain intensity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first ambulation;Duration of chest tube placement;Postoperative length of hospital stay; | — |
Countries
China
Contacts
Public ContactJing Yibing
Yixing Hospital of Traditional Chinese Medicine
Outcome results
None listed